{"id":429393,"date":"2021-02-04T16:05:07","date_gmt":"2021-02-04T21:05:07","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=429393"},"modified":"2021-02-04T16:05:07","modified_gmt":"2021-02-04T21:05:07","slug":"fluidigm-to-participate-in-btig-virtual-medtech-digital-health-life-science-and-diagnostic-tools-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/fluidigm-to-participate-in-btig-virtual-medtech-digital-health-life-science-and-diagnostic-tools-conference\/","title":{"rendered":"Fluidigm to Participate in BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">SOUTH SAN FRANCISCO, Calif., Feb.  04, 2021  (GLOBE NEWSWIRE) &#8212; Fluidigm Corporation\u00a0(Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that the company\u2019s management will participate in investor meetings at the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference on Thursday, February 18, 2021.<\/p>\n<p>Chris Linthwaite, President and CEO, will participate in a virtual fireside chat and present updates regarding Fluidigm\u2019s business strategy and financial performance at 2:00 pm ET. A live webcast and subsequent replay will be available in the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Q2g5Fn7Oi1BpWCw0VXSRd-_nMcYROF-5FgL_oMlm_WEf8I0uHT1uYQhzQJrm3_y9RLL0JSU59vnDDPKycA4JSMQg1I-nHKDpDkiVvY22b-1uAEtOovwdIyZFjnsJ2bl0uHECD1aQOqQeADe2mVrPfg==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>Events &amp; Presentations<\/u><\/a> section of the Fluidigm investor website. The replay will be available two hours after the live session and will be archived for the following 90 days.<\/p>\n<p>\n        <strong>About Fluidigm<\/strong><br \/>\n        <br \/>Fluidigm\u00a0(Nasdaq:FLDM) focuses on the most pressing needs in translational and clinical research, including cancer, immunology, and immunotherapy. Using proprietary CyTOF<sup>\u00ae<\/sup>\u00a0and microfluidics technologies, we develop, manufacture, and market multi-omic solutions to drive meaningful insights in health and disease, identify biomarkers to inform decisions, and accelerate the development of more effective therapies. Our customers are leading academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories worldwide. Together with them, we strive to increase the quality of life for all. For more information, visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=i4N9hXF_xvXFy5ggMSaPzsawTaMgjaQsQJfJacZhwk--YJscntWPc1ryGnCvv-dOR06JsYrfv3VsnGRqFKevnA==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">fluidigm.com<\/a>.<\/p>\n<p>Fluidigm, the\u00a0Fluidigm\u00a0logo,\u00a0Advanta\u00a0and CyTOF are trademarks and\/or registered trademarks of\u00a0Fluidigm Corporation\u00a0in\u00a0the United States\u00a0and\/or other countries. All other trademarks are the sole property of their respective owners.\u00a0The Advanta\u2122 Dx SARS-CoV-2 RT-PCR Assay is for\u00a0<em>In Vitro<\/em>\u00a0Diagnostic Use. It is for Use under Emergency Use Authorization Only. Rx Only. Other\u00a0Fluidigm\u00a0products are provided for Research Use Only. Not for use in diagnostic procedures.<\/p>\n<p>\n        <strong>Available Information<\/strong><br \/>\n        <strong><br \/>\n          <br \/>\n        <\/strong>We use our website (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=i4N9hXF_xvXFy5ggMSaPzl-kip6lJRUIuF2aFaIin1NKYftN4xvs3BlIjoLxlbd9SuCOjmFVwXOX4ceh-vxSsw==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">fluidigm.com<\/a>), investor site (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=NeKq5_ik4pQV1qye2VXZMOoIgWUOJ9Pe1JVOfwn8uKLDEaOoxuaBvmRAJV86TubfBRBJEvqF3NulcUoTfpn_-4o5L4MdmHYR75vmxEZwfEA=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">investors.fluidigm.com<\/a>), corporate Twitter account (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=8hOmRs8p4O-AKyDyhScL1mxrViUHykA1rkDJOZgEVw0tRSO6GoQlb0susWlgYZIMTgIYKJCqmy9vtUPPBHwbJqgkdp7zxysEgvVZHGwjzTYPDQifirgIfBMVkgHBCRh0E3E29BgeaM4_JUsCgtGxSGSWdr7WT_4WfKzY192r4AG8Td4wRaZmabNtwhkiMGgzOxrsgvXWwDroyBBJENiICZaLDje7uXs8WLdiSJF-yuY=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">@fluidigm<\/a>), Facebook page (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=JBaRRSIPrJKYvtwysjn2BGP0epq5qW0RTu4FogEbSfh5ixe6xnLXDfOOejhSQsso-yjWRmIRL7xayk1p1bifpy75PJNl4-lQ6MbMn-pkSeo1JK1y308nOvS6KCpqPYPQ4P07xW2X7v4Kgmo7Hs32-Ks5SBKNHVyw8SwKi4nGZVQ1nDyfATI7K1-cwkNy78D1_hs7lvntdBQyjGAF806oGWxZSewZY_Ewhp0jgHXlWTJrSNE_Re7stSRXNAEgASLegMZWvGM83QpF9mT7AABsjg==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">facebook.com\/Fluidigm<\/a>), and LinkedIn page (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ZSXohzOqaOusrnGxkMv9yVOJRvGCnKBvmGj8oL2kH7A6_ehO9MErRLBQvLdShTYFbfUT7gr7ZptKXQghShnNGE0RQAd1ffgan1mPaFsjgTxaeyFq_6UKXMDGHYwIhUyFv94ZmnEjZsfi53Ai_Lif_3_BSZgJU9_acRM8I6hnWg4gZbVk-ONJ-BHaVr5Sr-iLwVo5qOG77wkQPBjUvox7XTLAtUvqbjwyb6p-tRgGmV03VMCOw_w7bCtdH7Ks-yD2_bu7CEeIthQPHttkXYCQzYn0U3hYS3JUK_Ku-OFqg8Siw0PCGcDdIRGg2Al_t8W2-li_I6BbHQyPsruStdrwRnGrez7mtky93WXmfACd6X8uw05BIsMaS84YWzBUMOHM\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">linkedin.com\/company\/fluidigm-corporation<\/a>) as channels of distribution of information about our products, our planned financial and other announcements, our attendance at upcoming investor and industry conferences, and other matters. Such information may be deemed material information, and we may use these channels to comply with our disclosure obligations under Regulation FD. Therefore, investors should monitor our website and our social media accounts in addition to following our press releases,\u00a0SEC\u00a0filings, public conference calls, and webcasts.<\/p>\n<p>\n        <strong>Contact:<\/strong>\n      <\/p>\n<p>Agnes Lee<br \/>Vice President, Investor Relations<br \/>Fluidigm Corporation<br \/>650 416 7423<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=RvED6oP7urJENgkhLCUWVxmuzgA4PbfPhdOS5b37uEDXpexMUqk98Ch9DZ5yGtnk5iXAUnpWixDaBF2rNqoQ2Y2-G04ZV0bApQZelcBynxo=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>agnes.lee@fluidigm.com<\/u><\/a><\/p>\n<p \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE0NzY4MSMzOTYxODIzIzIwMDM4MTg=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/8bf8f9c7-805a-4c3d-bec3-68ac215bafaf\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SOUTH SAN FRANCISCO, Calif., Feb. 04, 2021 (GLOBE NEWSWIRE) &#8212; Fluidigm Corporation\u00a0(Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that the company\u2019s management will participate in investor meetings at the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference on Thursday, February 18, 2021. Chris Linthwaite, President and CEO, will participate in a virtual fireside chat and present updates regarding Fluidigm\u2019s business strategy and financial performance at 2:00 pm ET. A live webcast and subsequent replay will be available in the Events &amp; Presentations section of the Fluidigm investor website. The replay will be available two hours after the live session and will be archived for the following &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/fluidigm-to-participate-in-btig-virtual-medtech-digital-health-life-science-and-diagnostic-tools-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Fluidigm to Participate in BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-429393","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Fluidigm to Participate in BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/fluidigm-to-participate-in-btig-virtual-medtech-digital-health-life-science-and-diagnostic-tools-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Fluidigm to Participate in BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SOUTH SAN FRANCISCO, Calif., Feb. 04, 2021 (GLOBE NEWSWIRE) &#8212; Fluidigm Corporation\u00a0(Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that the company\u2019s management will participate in investor meetings at the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference on Thursday, February 18, 2021. Chris Linthwaite, President and CEO, will participate in a virtual fireside chat and present updates regarding Fluidigm\u2019s business strategy and financial performance at 2:00 pm ET. A live webcast and subsequent replay will be available in the Events &amp; Presentations section of the Fluidigm investor website. The replay will be available two hours after the live session and will be archived for the following &hellip; Continue reading &quot;Fluidigm to Participate in BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/fluidigm-to-participate-in-btig-virtual-medtech-digital-health-life-science-and-diagnostic-tools-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-02-04T21:05:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE0NzY4MSMzOTYxODIzIzIwMDM4MTg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fluidigm-to-participate-in-btig-virtual-medtech-digital-health-life-science-and-diagnostic-tools-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fluidigm-to-participate-in-btig-virtual-medtech-digital-health-life-science-and-diagnostic-tools-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Fluidigm to Participate in BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference\",\"datePublished\":\"2021-02-04T21:05:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fluidigm-to-participate-in-btig-virtual-medtech-digital-health-life-science-and-diagnostic-tools-conference\\\/\"},\"wordCount\":411,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fluidigm-to-participate-in-btig-virtual-medtech-digital-health-life-science-and-diagnostic-tools-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE0NzY4MSMzOTYxODIzIzIwMDM4MTg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fluidigm-to-participate-in-btig-virtual-medtech-digital-health-life-science-and-diagnostic-tools-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fluidigm-to-participate-in-btig-virtual-medtech-digital-health-life-science-and-diagnostic-tools-conference\\\/\",\"name\":\"Fluidigm to Participate in BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fluidigm-to-participate-in-btig-virtual-medtech-digital-health-life-science-and-diagnostic-tools-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fluidigm-to-participate-in-btig-virtual-medtech-digital-health-life-science-and-diagnostic-tools-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE0NzY4MSMzOTYxODIzIzIwMDM4MTg=\",\"datePublished\":\"2021-02-04T21:05:07+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fluidigm-to-participate-in-btig-virtual-medtech-digital-health-life-science-and-diagnostic-tools-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fluidigm-to-participate-in-btig-virtual-medtech-digital-health-life-science-and-diagnostic-tools-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fluidigm-to-participate-in-btig-virtual-medtech-digital-health-life-science-and-diagnostic-tools-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE0NzY4MSMzOTYxODIzIzIwMDM4MTg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE0NzY4MSMzOTYxODIzIzIwMDM4MTg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fluidigm-to-participate-in-btig-virtual-medtech-digital-health-life-science-and-diagnostic-tools-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Fluidigm to Participate in BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Fluidigm to Participate in BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/fluidigm-to-participate-in-btig-virtual-medtech-digital-health-life-science-and-diagnostic-tools-conference\/","og_locale":"en_US","og_type":"article","og_title":"Fluidigm to Participate in BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference - Market Newsdesk","og_description":"SOUTH SAN FRANCISCO, Calif., Feb. 04, 2021 (GLOBE NEWSWIRE) &#8212; Fluidigm Corporation\u00a0(Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that the company\u2019s management will participate in investor meetings at the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference on Thursday, February 18, 2021. Chris Linthwaite, President and CEO, will participate in a virtual fireside chat and present updates regarding Fluidigm\u2019s business strategy and financial performance at 2:00 pm ET. A live webcast and subsequent replay will be available in the Events &amp; Presentations section of the Fluidigm investor website. The replay will be available two hours after the live session and will be archived for the following &hellip; Continue reading \"Fluidigm to Participate in BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/fluidigm-to-participate-in-btig-virtual-medtech-digital-health-life-science-and-diagnostic-tools-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2021-02-04T21:05:07+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE0NzY4MSMzOTYxODIzIzIwMDM4MTg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fluidigm-to-participate-in-btig-virtual-medtech-digital-health-life-science-and-diagnostic-tools-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fluidigm-to-participate-in-btig-virtual-medtech-digital-health-life-science-and-diagnostic-tools-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Fluidigm to Participate in BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference","datePublished":"2021-02-04T21:05:07+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fluidigm-to-participate-in-btig-virtual-medtech-digital-health-life-science-and-diagnostic-tools-conference\/"},"wordCount":411,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fluidigm-to-participate-in-btig-virtual-medtech-digital-health-life-science-and-diagnostic-tools-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE0NzY4MSMzOTYxODIzIzIwMDM4MTg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fluidigm-to-participate-in-btig-virtual-medtech-digital-health-life-science-and-diagnostic-tools-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/fluidigm-to-participate-in-btig-virtual-medtech-digital-health-life-science-and-diagnostic-tools-conference\/","name":"Fluidigm to Participate in BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fluidigm-to-participate-in-btig-virtual-medtech-digital-health-life-science-and-diagnostic-tools-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fluidigm-to-participate-in-btig-virtual-medtech-digital-health-life-science-and-diagnostic-tools-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE0NzY4MSMzOTYxODIzIzIwMDM4MTg=","datePublished":"2021-02-04T21:05:07+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fluidigm-to-participate-in-btig-virtual-medtech-digital-health-life-science-and-diagnostic-tools-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/fluidigm-to-participate-in-btig-virtual-medtech-digital-health-life-science-and-diagnostic-tools-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fluidigm-to-participate-in-btig-virtual-medtech-digital-health-life-science-and-diagnostic-tools-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE0NzY4MSMzOTYxODIzIzIwMDM4MTg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE0NzY4MSMzOTYxODIzIzIwMDM4MTg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fluidigm-to-participate-in-btig-virtual-medtech-digital-health-life-science-and-diagnostic-tools-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Fluidigm to Participate in BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/429393","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=429393"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/429393\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=429393"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=429393"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=429393"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}